Dries De Wolf: Honored to Have Wolfgang Miesbach Comment on Our Latest Research
Dries De Wolf, Postdoctoral Researcher at the Institute of Regenerative Medicine (IREM), shared a post on LinkedIn:
“It is a true honor to have Wolfgang Miesbach write a commentary on our latest research paper in Blood Advances (American Society of Hematology).
The title of the commentary ‘Doing more with less in hemophilia B gene therapy’ perfectly addresses a central unsolved problem:
How to ensure that more patients reach a durably protective factor IX level – a problem we tried to solve by focusing on the transgene and extending the half-life of the gene therapy-derived factor IX.
Thank you, Wolfgang Miesbach.”
Title 1: Increased gene therapy efficacy through the use of extended half-life clotting factors
Authors: Dries De Wolf, Phuong Anh Nguyen, Nisha Nair, Fangye Gao, Venkata Anudeep Bheemsetty, Ermira Samara-Kuko, Marinee K. Chuah, Thierry VandenDriessche
Read the Full Article on Blood Advances
Title 2: Doing more with less in hemophilia B gene therapy
Authors: Wolfgang Miesbach
Read the Full Article on Blood Advances
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 12, 2026, 17:53Usman Waheed: Introducing the Discovery of the 49th ISBT Blood Group System
-
Sep 12, 2026, 17:51Maria Sabater Lleal: Happy to Share Our Latest Work Exploring the Genetic Determinants of PE in VTE
-
Sep 12, 2026, 17:51Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?
-
Sep 12, 2026, 17:49Kalyan Roy: TRAGS – An Emerging Transfusion Safety Concern
-
Sep 12, 2026, 17:48Jason Fung: What Happened to “Statins Save Lives”?
-
Sep 12, 2026, 17:47Eric Topol: Most Supplements and Vitamins Offer Little Proven Benefit
-
Sep 12, 2026, 17:44Manuel Monreal: Clinical Characteristics, Treatment, and Outcomes in Hispanic vs Caucasian Patients With VTE
-
Sep 12, 2026, 17:43Sidi Mohamed El Amine Benlazar: CPX-351 and Ruxolitinib in Advanced-Phase Myeloproliferative Neoplasms
-
Sep 12, 2026, 17:42Elad Asher: Higher IPF Is Associated with Adverse Outcomes in ICCU